| Document Date: 2010-11-01 16:40:13
Open Document File Size: 57,00 KBShare Result on Facebook
Company MedImmune / Eisai / Cephalon / AstraZeneca / MediQuest Therapeutics Inc. / Johnson & Johnson / / Country Switzerland / United States / Canada / / Event FDA Phase / / IndustryTerm vascular-enhanced magnetic resonance imaging / manufacturing / / MedicalCondition Pseudomonas / disease / peripheral arterial disease / iron deficiency anemia / osteomyelitis / pain / Raynaud’s Disease / septic shock / skin infections / severe rheumatoid arthritis / soft tissue infections / adjunctive therapy partial-onset seizures / skin and skin structure infections ( csssi ) / penicillin-resistant Streptococcus pneumonia / sepsis / / MedicalTreatment adjunctive therapy / / Organization European Medicines Agency / FDA / Committee for Medicinal Products for Human Use / European Union / / Position investigator / / Product penicillin / Fentanyl / Vicodin / Fentora / Onsolis / Fibrosis Drug / _Vascana_ / / Technology magnetic resonance imaging / /
SocialTag |
Date Manufacturer Product Indication Biologic or Drug Reason/Comments[removed] JNJ Paliperidone Palmitate Schizophrenia Drug N/A[removed] BioDelivery Sciences Bema Fentanyl, which will be marketed in the US as Onsolis